MetLife Investment Management’s Everus Construction Group ECG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Buy
2,554
+1,721
+207% +$252K ﹤0.01% 2011
2026
Q1
$98.3K Buy
833
+1
+0.1% +$103 ﹤0.01% 2551
2025
Q4
$71.2K Sell
832
-16
-2% -$1.43K ﹤0.01% 2692
2025
Q3
$72.7K Buy
848
+1
+0.1% +$74 ﹤0.01% 2755
2025
Q2
$53.8K Sell
847
-65
-7% -$3.29K ﹤0.01% 2681
2025
Q1
$33.8K Buy
912
+20
+2% +$1.08K ﹤0.01% 2722
2024
Q4
$58.6K Buy
+892
New +$56.1K ﹤0.01% 2726

Other funds holding ECG

MetLife Investment Management's ECG Position: Q2 2026 in Review

MetLife Investment Management increased its Everus Construction Group (ECG) stake by 207% in Q2 2026, buying an estimated $252K and bringing the position to 2,554 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

MetLife Investment Management first reported a position in ECG in Q4 2024 and has held it in 7 quarters since. 539 funds tracked by Wall St. Rank hold ECG as of Q2 2026.

  • MetLife Investment Management held 2,554 shares of Everus Construction Group worth $424K as of Q2 2026.
  • MetLife Investment Management bought 1,721 Everus Construction Group shares in Q2 2026, an estimated $252K.
  • Everus Construction Group made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2011 holding.
  • MetLife Investment Management first reported a position in Everus Construction Group in Q4 2024 and has held it in 7 quarters since.
  • 539 funds tracked by Wall St. Rank held Everus Construction Group as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.